As observed in CLL patients (Fig. 1a), fludarabine significantly induced UGT2B17 expression in MEC1, JVM2, and EHEB cellular models (Fig. 2a–c). This evidence concerns the gene ATR and B-cell chronic lymphocytic leukemia.